Skip to main content
PMC home page
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2005 Apr 1;26(4):405–416. doi: 10.1111/j.1745-7254.2005.00078.x

Baculovirus as a highly efficient expression vector in insect and mammalian cells

Yu‐chen HU 1,✉
PMCID: PMC7091893  PMID: 15780188

Abstract

Baculovirus has been widely used for the production of recombinant proteins in insect cells. Since the finding that baculovirus can efficiently transduce mammalian cells, the applications of baculovirus have been greatly expanded. The prospects and drawbacks of baculovirus‐mediated gene expression, either in insect or in mammalian cells, are reviewed. Recent progresses in expanding the applications to studies of gene regulation, viral vector preparation, in vivo and ex vivo gene therapy studies, generation of vaccine vectors, etc are discussed and the efforts directed towards overcoming the existing bottlenecks are particularly emphasized.

Keywords: baculovirus, insect cell, mammalian cell, gene therapy, vaccine, recombinant protein

References

  • 1. Wood HA. Development and testing of genetically improved baculovirus insecticides In: Shuler ML, Wood HA, Granados RR, Hammer DA, editors. Baculovirus expression systems and biopesticides. New York : Wiley‐Liss; 1995. p. 91–102. [Google Scholar]
  • 2. Patterson RM, Selkirk JK, Merrick BA. Baculovirus and insect cell gene expression‐review of baculovirus biotechnology. Environ Health Perspect 1995; 103: 756–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Luckow VA, Summers MD. Trends in the development of baculovirus expression vectors. Biotechnology 1988; 6: 47–55. [Google Scholar]
  • 4. Beljelarskaya SN. A baculovirus expression system for insect cells. Mol Biol 2002; 36: 281–92. [Google Scholar]
  • 5. Ikonomou L, Schneider YJ, Agathos SN. Insect cell culture for industrial production of recombinant proteins. Appl Microbiol Biotechnol 2003; 62: 1–20. [DOI] [PubMed] [Google Scholar]
  • 6. Cha HJ, Pham MQ, Rao G, Bentley WE. Expression of green fluorescent protein in insect larvae and its application for heterologous protein production. Biotechnol Bioeng 1997; 56: 239–47. [DOI] [PubMed] [Google Scholar]
  • 7. Cha HJ, Dalal NG, Pham MQ, Vakharia VN, Rao G, Bentley WE. Insect larval expression process is optimized by generating fusions with green fluorescent protein. Biotechnol Bioeng 1999;65: 316–24. [DOI] [PubMed] [Google Scholar]
  • 8. Lihoradova OA, Bachurina EY, Azimova SS. Biosynthesis of the recombinant middle surface antigen of the human hepatitis B virus in silkworm larvae. Mol Biol 2004; 38: 603–7. [PubMed] [Google Scholar]
  • 9. Maeda S. Expression of foreign genes in insects using baculovirus vectors. Ann Rev Entomol 1989; 34: 351–72. [DOI] [PubMed] [Google Scholar]
  • 10. Palhan VB, Sumathy S, Gopinathan KP. Baculovirus mediated high‐level expression of luciferase in silkworm cells and larvae. Biotechniques 1995; 19: 97–104. [PubMed] [Google Scholar]
  • 11. Medin JA, Hunt L, Gathy K, Evans RK, Coleman MS. Efficient, low‐cost protein factories: expression of human adenosine deaminase in baculovirus‐infected insect larvae. Proc Natl Acad Sci USA 1990; 87: 2760–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Casal JI. Use of parvovirus‐like particles for vaccination and induction of multiple immune responses. Biotechnol Appl Biochem 1999; 29: 141–50. [PubMed] [Google Scholar]
  • 13. Lenz P, Day PM, Pang YYS, Frye SA, Jensen PN, Lowy DR, et al. Papillomavirus‐like particles induce acute activation of dendritic cells. J Immunol 2001; 166: 5346–55. [DOI] [PubMed] [Google Scholar]
  • 14. Schiller JT, Lowy DR. Papillomavirus‐like particle based vaccines: cervical cancer and beyond. Expert Opin Biol Ther 2001; 1: 571–81. [DOI] [PubMed] [Google Scholar]
  • 15. Roy P. Genetically engineered particulate virus‐like structures nd their use as vaccine delivery systems. Intervirology 1996; 9: 62–71. [DOI] [PubMed] [Google Scholar]
  • 16. Xiang J, Wunschmann S, George SL, Klinzman D, Schmidt WN, LaBrecque DR, et al. Recombinant hepatitis C virus‐like particles xpressed by baculovirus: utility in cell‐binding and antibody etection assays. J Med Virol 2002; 68: 537–43. [DOI] [PubMed] [Google Scholar]
  • 17. Touze A, Bousarghin L, Ster C, Combita AL, Roingeard P, Coursaget P. Gene transfer using human polyomavirus BK viruslike articles expressed in insect cells. J Gen Virol 2001; 82: 005–9. [DOI] [PubMed] [Google Scholar]
  • 18. Tegerstedt K, Andreasson K, Vlastos A, Hedlund KO, Dalianis T, Ramqvist T. Murine pneumotropic virus VP1 virus‐like particles VLPs) bind to several cell types independent of sialic acid esidues and do not serologically cross react with murine olyomavirus VP1 VLPs. J Gen Virol 2003; 84: 3443–52. [DOI] [PubMed] [Google Scholar]
  • 19. Luo L, Li Y, Cannon P, Kim S, Kang CY. Chimeric gag‐V3 viruslike articles of human immunodeficiency virus induce virusneutralizing ntibodies. Proc Natl Acad Sci USA 1992; 89: 10527–31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Tatman JD, Preston VG, Nicholson P, Elliott RM, Rixon FJ. ssembly of herpes simplex virus type 1 capsids using a panel of ecombinant baculoviruses. J Gen Virol 1994; 75: 1101–13. [DOI] [PubMed] [Google Scholar]
  • 21. Volpers C, Schirmacher P, Streeck RE, Sapp M. Assembly of the ajor and the minor capsid protein of human papillomavirustype 33 into virus‐like particles and tubular structures in insect ells. Virology 1994; 200: 504–12. [DOI] [PubMed] [Google Scholar]
  • 22. Gillock ET, Rottinghaus S, Chang D, Cai X, Smiley SA, An K, et al. Polyomavirus major capsid protein VP1 is capable of ackaging cellular DNA when expressed in the baculovirus system. Virol 1997; 71: 2857–65. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Kajigaya S, Fujii H, Field A, Anderson S, Rosenfeld S, Anderson L, et al. Self‐assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions. Proc Natl Acad Sci USA 1991; 88: 4646–50. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Hu YC, Bentley WE, Edwards GH, Vakharia VN. Chimeric infectious bursal disease virus‐like particles expressed in insect cells and purified by immobilized metal affinity chromatography. Biotechnol Bioeng 1999; 63: 721–9. [DOI] [PubMed] [Google Scholar]
  • 25. Hu YC, Hsu TA, Huang JH, Ho MS, Ho YC. Formation of enterovirus‐like particle aggregates by recombinant baculoviruses co‐expressing P1 and 3CD in insect cells. Biotechnol Lett 2003; 25: 919–25. [DOI] [PubMed] [Google Scholar]
  • 26. Ho Y, Lin PH, Liu CYY, Lee SP, Chao YC. Assembly of human severe acute respiratory syndrome coronavirus‐like particles. Biochem Biophys Res Commun 2004; 318: 833–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Mortola E, Roy P. Efficient assembly and release of SARS coronavirus‐like particles by a heterologous expression system. FEBS Lett 2004; 576: 174–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Tsao E, Mason M, Cacciuttolo M, Bowen S, Wassweman G. Production of parvovirus B19 vaccine in insect cells co‐infected with double baculovirus. Biotechnol Bioeng 1996; 49: 130–8. [DOI] [PubMed] [Google Scholar]
  • 29. Wang C, Olsen J, Zhang Y, Barklis E. Assembly of HIV GAG‐agalactosidase fusion proteins into virus particles. Virology 1994; 200: 524–34. [DOI] [PubMed] [Google Scholar]
  • 30. Conner M, Zarley C, Hu B, Parsons S, Drabinski D, Greiner S, et al. Virus‐like particles as a rotavirus subunit vaccine. J Infect Dis 1996; 174: S88–S92. [DOI] [PubMed] [Google Scholar]
  • 31. Gerhardt E, Bruss V. Phenotypic mixing of rodent but not avian hepadnavirus surface proteins into human hepatitis B virus particles. J Virol 1995; 69: 1201–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Jarvis DL, Fleming J, Kovacs GR, Summers MD, Guarino LA. Use of early baculovirus promoters for continuous expression and efficient processing of foreign gene products in stably transformed lepidopteran cells. Biotechnology 1990; 8: 950–55. [DOI] [PubMed] [Google Scholar]
  • 33. Ho Y, Lo HR, Lee TC, Wu CP, Chao YC. Enhancement of correct protein folding in vivo by a non‐lytic baculovirus. Biochem J 2004; 382: 695–702. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Raju TS, Lerner L, O'Connor JV. Glycopinion: biological significance and methods for the analysis of complex carbohydrates of recombinant glycoproteins. Biotechnol Appl Biochem 1996; 24: 191–4. [PubMed] [Google Scholar]
  • 35. Hollister JR, Shaper JH, Jarvis DL. Stable expression of mammalian beta 1,4‐galactosyltransferase extends the N ‐glycosylation pathway in insect cells. Glycobiology 1998; 8: 473–80. [DOI] [PubMed] [Google Scholar]
  • 36. Hollister JR, Jarvis DL. A stably‐transformed insect cell line engineered to support asialoglycoprotein production by baculovirus expression vectors. Glycobiology 1999; 9: 1124. [Google Scholar]
  • 37. Altmann F, Staudacher E, Wilson IBH, Marz L. Insect cells as hosts for the expression of recombinant glycoproteins. Glycoconj J 1999; 16: 109–23. [DOI] [PubMed] [Google Scholar]
  • 38. Jarvis DL. Developing baculovirus‐insect cell expression systems for humanized recombinant glycoprotein production. Virology 2003; 310: 1–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Jarvis DL, Aumiller JJ, Hollister JR, Kawar ZS, Pilon J, Vadaie N. Analysis and manipulation of the protein N ‐glycosylation pathway in the baculovirus‐insect cell system. Glycobiology 2004; 14: 1059–60. [Google Scholar]
  • 40. Laprise M‐H, Grondin F, Dubois CM. Enhanced TGFβ1 maturation in high five cells coinfected with recombinant baculovirus encoding the convertase furin/pace: improved technology for the production of recombinant proproteins in insect cells. Biotechnol Bioeng 1998; 58: 85–91. [PubMed] [Google Scholar]
  • 41. Volkman LE, Goldsmith PA. In vitro study of Autographa californica nuclear polyhedrosis virus interaction with nontarget vertebrate host cells. Appl Environ Microbiol 1983; 45: 1085–93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Carbonell LF, Klowden MJ, Miller LK. Baculovirus‐mediated expression of bacterial genes in dipteran and mammalain cells. J Virol 1985; 56: 153–60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Hofmann C, Sandig V, Jennings G, Rudolph M, Schlag P, Strauss M. Efficient gene‐transfer into human hepatocytes by baculovirus vectors. Proc Natl Acad Sci USA 1995; 92: 10 099–103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Boyce FM, Bucher NLR. Baculovirus‐mediated gene transfer to mammalian cells. Proc Natl Acad Sci USA 1996; 93: 2348–52. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Shoji I, Aizaki H, Tani H, Ishii K, Chiba T, Saito I, et al. Efficient ene transfer into various mammalian cells, including nonhepatic cells, by baculovirus vectors. J Gen Virol 1997; 78: 2657–64. [DOI] [PubMed] [Google Scholar]
  • 46. Kost TA, Condreay JP. Recombinant baculoviruses as mammalian cell gene delivery vectors. Trends Biotechnol 2002; 20: 173–80. [DOI] [PubMed] [Google Scholar]
  • 47. Leisy DJ, Lewis TD, Leong JAC, Rohrmann GF. Transduction of cultured fish cells with recombinant baculoviruses. J Gen Virol 2003; 84: 1173–8. [DOI] [PubMed] [Google Scholar]
  • 48. van Loo ND, Fortunati E, Ehlert E, Rabelink M, Grosveld F, Scholte BJ. Baculovirus infection of nondividing mammalian cells: mechanisms of entry and nuclear transport of capsids. J Virol 2001; 75: 961–70. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49. Sarkis C, Serguera C, Petres S, Buchet D, Ridet JL, Edelman L, et al. Efficient transduction of neural cells in vitro and in vivo by a baculovirus‐derived vector. Proc Natl Acad Sci USA 2000; 97: 14638–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Ma L, Tamarina N, Wang Y, Kuznetsov A, Patel N, Kending C, et al. Baculovirus‐mediated gene transfer into pancreatic islet cells. Diabetes 2000; 49: 1986–91. [DOI] [PubMed] [Google Scholar]
  • 51. Ho YC, Chen HC, Wang KC, Hu YC. Highly efficient baculovirusmediated gene transfer into rat chondrocytes. Biotechnol Bioeng 2004; 88: 643–51. [DOI] [PubMed] [Google Scholar]
  • 52. Wagle M, Jesuthasan S. Baculovirus‐mediated gene expression in zebrafish. Marine Biotechnol 2003; 5: 58–63. [DOI] [PubMed] [Google Scholar]
  • 53. Condreay JP, Witherspoon SM, Clay WC, Kost TA. Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector. Proc Natl Acad Sci USA 1999; 96: 127–32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. Cheng T, Xu CY, Wang YB, Chen M, Wu T, Zhang J, et al. A rapid and efficient method to express target genes in mammalian cells by baculovirus. World J Gastroenterol 2004; 10: 1612–18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Lo HR, Chou CC, Wu TY, Yuen JP, Chao YC. Novel baculovirus DNA elements strongly stimulate activities of exogenous and endogenous promoters. J Biol Chem 2002; 277: 5256–64. [DOI] [PubMed] [Google Scholar]
  • 56. Venkaiah B, Viswanathan P, Habib S, Hasnain SE. An additional copy of the homologous region (hr1) sequence in the Autographa californica multinucleocapsid polyhedrosis virus genome promotes hyperexpression of foreign genes. Biochemistry 2004; 43: 8143–51. [DOI] [PubMed] [Google Scholar]
  • 57. Viswanathan P, Venkaiah B, Kumar MS, Rasheedi S, Vrati S, Bashyam MD, et al. The homologous region sequence (hr1) of Autographa californica multinucleocapsid polyhedrosis virus can enhance transcription from non‐baculoviral promoters in mammalian cells. J Biol Chem 2003; 278: 5264–71. [DOI] [PubMed] [Google Scholar]
  • 58. Pijlman GP, de Vrij J, van den End FJ, Vlak JM, Martens DE Evaluation of baculovirus expression vectors with enhanced stability in continuous cascaded insect‐cell bioreactors. Biotechnol Bioeng 2004; 87: 743–53. [DOI] [PubMed] [Google Scholar]
  • 59. Pijlman GP, van den Born E, Martens DE, Vlak JM. Autographa californica baculoviruses with large genomic deletions are rapidly generated in infected insect cells. Virology 2001; 283: 132–8. [DOI] [PubMed] [Google Scholar]
  • 60. Hu YC, Tsai CT, Chang YJ, Huang JH. Enhancement and prolongation of baculovirus‐mediated expression in mammalian cells: Focuses on strategic infection and feeding. Biotechnol Prog 2003; 19: 373–9. [DOI] [PubMed] [Google Scholar]
  • 61. Tani H, Limn CK, Yap CC, Onishi M, Nozaki M, Nishimune Y, et al. In vitro and in vivo gene delivery by recombinant baculoviruses. J Virol 2003; 77: 9799–808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62. Hsu CS, Ho YC, Wang KC, Hu YC. Investigation of optimal transduction conditions for baculovirus‐mediated gene delivery into mammalian cells. Biotechnol Bioeng 2004; 88: 42–51. [DOI] [PubMed] [Google Scholar]
  • 63. Ho YC, Chung YC, Hwang SM, Wang KC, Hu YC. Transgene expression and differentiation of baculovirus‐transduced human mesenchymal stem cells. J Gene Med 2005; in press. [DOI] [PubMed] [Google Scholar]
  • 64. Gao R, McCormick CJ, Arthur MJP, Ruddle R, Oakley F, Smart DE, et al. High efficiency gene transfer into cultured primary rat and human hepatic stellate cells using baculovirus vectors. Liver 2002; 22: 15–22. [DOI] [PubMed] [Google Scholar]
  • 65. Detrait, ER , Bowers, WJ , Halterman, MW , Giuliano, RE , Bennice, L , Federoff, HJ , et al Reporter gene transfer induces apoptosis in primary cortical neurons. Mol Ther 2002; 5: 723–30. [DOI] [PubMed] [Google Scholar]
  • 66. Liu HS, Jan MS, Chou CK, Chen PH, Ke NJ. Is green fluorescent protein toxic to the living cells? Biochem Biophys Res Commun 1999; 260: 712–17. [DOI] [PubMed] [Google Scholar]
  • 67. Wang YC, Huang CF, Tung SF, Lin YS. Competition with TATA box‐binding protein for binding to the TATA box implicated in human cytomegalovirus IE2‐mediated transcriptional repression of cellular promoters. DNA Cell Biol 2000; 19: 613–19. [DOI] [PubMed] [Google Scholar]
  • 68. Dee KU, Shuler ML. A mathematical model of the trafficking of acid‐dependent enveloped viruses: application to the binding, uptake, and nuclear accumulation of baculovirus. Biotechnol Bioeng 1997; 54: 468–90. [DOI] [PubMed] [Google Scholar]
  • 69. Duisit G, Saleun S, Douthe S, Barsoum J, Chadeuf G, Moullier P. Baculovirus vector requires electrostatic interactions including heparan sulfate for efficient gene transfer in mammalian cells. J Gene Med 1999; 1: 93–102. [DOI] [PubMed] [Google Scholar]
  • 70. Hofmann C, Lehnet W, Strauss M. The baculovirus system for gene delivery into hepatocytes. Gene Ther Mol Biol 1998; 1: 231–9. [Google Scholar]
  • 71. Tani H, Nishijima M, Ushijima H, Miyamura T, Matsuura Y. Characterization of cell‐surface determinants important for baculovirus infection. Virology 2001; 279: 343–53. [DOI] [PubMed] [Google Scholar]
  • 72. Bilello JP, Cable EE, Myers RL, Isom HC. Role of paracellular junction complexes in baculovirus‐mediated gene transfer to nondividing rat hepatocytes. Gene Ther 2003; 10: 733–49. [DOI] [PubMed] [Google Scholar]
  • 73. Barsoum J, Brown R, McKee M, Boyce FM. Efficient transduction of mammalian cells by a recombinant baculovirus having the vesicular stomatitis virus G glycoprotein. Hum Gene Ther 1997; 8: 2011–8. [DOI] [PubMed] [Google Scholar]
  • 74. Kukkonen SP, Ai renne KJ, Marjomaki V, Lai tinen OH, Lehtolainen P, Kankaanpaa P, et al. Baculovirus capsid display: a novel tool for transduction imaging. Mol Ther 2003; 8: 853–62. [DOI] [PubMed] [Google Scholar]
  • 75. Boublik Y, Di Bonito P, Jones IM. Eukaryotic virus display: engineering the major surface glycoprotein of the Autographa californica nuclear polyhedrosis virus (AcNPV) for the presentation of foreign proteins on the virus surface. Biotechnology 1995; 13: 1079–84. [DOI] [PubMed] [Google Scholar]
  • 76. Raty JK, Airenne KJ, Marttila AT, Marjomaki V, Hytonen VP, Lehtolainen P, et al. Enhanced gene delivery by avidin‐displaying baculovirus. Mol Ther 2004; 9: 282–91. [DOI] [PubMed] [Google Scholar]
  • 77. Mottershead DG, Alfthan K, Ojala K, Takkinen K, Oker‐Blom C. Baculoviral display of functional scFv and synthetic IgG‐binding domains. Biochem Biophys Res Commun 2000; 275: 84–90. [DOI] [PubMed] [Google Scholar]
  • 78. Ojala K, Mottershead DG, Suokko A, Oker‐Blom C. Specific binding of baculoviruses displaying gp64 fusion proteins to mammalian cells. Biochem Biophys Res Commun 2001; 284: 777–84. [DOI] [PubMed] [Google Scholar]
  • 79. Ernst W, Grabherr R, Wegner D, Borth N, Grassauer A, Katinger H. Baculovirus surface display: construction and screening of a eukaryotic epitope library. Nucleic Acids Res 1998; 26: 1718–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80. Cheshenko N, Krougliak N, Eisensmith RC, Krougliak VA. A novel system for the production of fully deleted adenovirus vectors that does not require helper adenovirus. Gene Ther 2001; 8: 846–54. [DOI] [PubMed] [Google Scholar]
  • 81. Sollerbrant K, Elmen J, Wahlestedt C, Acker J, Leblois‐Prehaud H, Latta‐Mahieu M, et al. A novel method using baculovirusmediated gene transfer for production of recombinant adenoassociated virus vectors. J Gen Virol 2001; 82: 2051–60. [DOI] [PubMed] [Google Scholar]
  • 82. Ramos L, Kopec LA, Sweitzer SM, Fornwald JA, Zhao HZ, McAllister P, et al. Rapid expression of recombinant proteins in modified CHO cells using the baculovirus system. Cytotechnology 2002; 38: 37–41. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83. Wang KC, Wu JC, Chung YC, Ho YC, Chang MD, Hu YC. Baculovirus as a highly efficient gene delivery vector for the expression of hepatitis delta virus antigens in mammalian cells. Biotechnol Bioeng 2005; 89: 464–73. [DOI] [PubMed] [Google Scholar]
  • 84. Chen YH, Wu JC, Wang KC, Chiang YW, Lai CW, Chung YC, et al. Baculovirus‐mediated production of HDV‐like particles in BHK cells using a novel oscillating bioreactor. J Biotechnol 2005; in press. [DOI] [PubMed] [Google Scholar]
  • 85. Clay WC, Condreay JP, Moore LB, Weaver SL, Watson MA, Kost TA, et al. Recombinant baculoviruses used to study estrogen receptor function in human osteosarcoma cells. Assay Drug Dev Technol 2003; 1: 801–10. [DOI] [PubMed] [Google Scholar]
  • 86. Jenkinson S, McCoy DC, Kerner SA, Ferris RG, Lawrence WK, Clay WC, et al. Development of a novel high‐throughput surrogate assay to measure HIV envelope/CCR5/CD4‐mediated viral/ cell fusion using BacMam baculovirus technology. J Biomol Screen 2003; 8: 463–70. [DOI] [PubMed] [Google Scholar]
  • 87. Delaney WE, Isom HC. Hepatitis B virus replication in human HepG2 cells mediated by hepatitis B virus recombinant baculovirus. Hepatology 1998; 28: 1134–46. [DOI] [PubMed] [Google Scholar]
  • 88. Fipaldini C, Bellei B, La Monica N. Expression of hepatitis C virus cDNA in human hepatoma cell line mediated by a hybrid baculovirus‐HCV vector. Virology 1999; 255: 302–11. [DOI] [PubMed] [Google Scholar]
  • 89. Delaney WE, Miller TG, Isom HC. Use of the hepatitis B virus recombinant baculovirus‐HepG2 system to study the effects of (‐)‐beta‐2′,3′‐dideoxy‐3′‐thiacytidine on replication of hepatitis B virus and accumulation of covalently closed circular DNA. Antimicrob Agents Chemother 1999; 43: 2017–26. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90. Delaney WE, Edwards R, Colledge D, Shaw T, Torresi J, Miller TG, et al. Cross‐resistance testing of antihepadnaviral compounds using novel recombinant baculoviruses which encode drugresistant strains of hepatitis B virus. Antimicrob Agents Chemother 2001; 45: 1705–13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91. McCormick CJ, Rowlands DJ, Harris M. Efficient delivery and regula ble expression of hepati tis C virus full‐length and minigenome constructs in hepatocyte‐derived cell lines using baculovirus vectors. J Gen Virol 2002; 83: 383–94. [DOI] [PubMed] [Google Scholar]
  • 92. Merrihew RV, Clay WC, Condreay JP, Witherspoon SM, Dallas WS, Kost TA. Chromosomal integration of transduced recombinant baculovirus DNA in mammalian cells. J Virol 2001; 75: 903–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93. Hofmann C, Strauss M. Baculovirus‐mediated gene transfer in the presence of human serum or blood facilitated by inhibition of the complement system. Gene Ther 1998; 5: 531–6. [DOI] [PubMed] [Google Scholar]
  • 94. Airenne KJ, Hiltunen MO, Turunen MP, Turunen AM, Laitinen OH, Kulomaa MS, et al. Baculovirus‐mediated periadventitial gene transfer to rabbit carotid artery. Gene Ther 2000; 7: 1499–1504. [DOI] [PubMed] [Google Scholar]
  • 95. Lehtolainen P, Tyynela K, Kannasto J, Airenne KJ, Yla‐Herttuala S. Baculoviruses exhibit restricted cell type specificity in rat brain: a comparison of baculovirus‐ and adenovirus‐mediated intracerebral gene transfer in vivo . Gene Ther 2002; 9: 1693–9. [DOI] [PubMed] [Google Scholar]
  • 96. Huser A, Rudolph M, Hofmann C. Incorporation of decay‐accelerating factor into the baculovirus envelope generates complement‐ resistant gene transfer vectors. Nature Biotechnol 2001; 19: 451–5. [DOI] [PubMed] [Google Scholar]
  • 97. Pieroni L, Maione D, La Monica N. In vivo gene transfer in mouse skeletal muscle mediated by baculovirus vectors. Hum Gene Ther 2001; 12: 871–81. [DOI] [PubMed] [Google Scholar]
  • 98. Bilello JP, Delaney WE, Boyce FM, Isom HC. Baculovirus entry into nondividing hepatocytes is enhanced by transient disruption of intercellular junctions. Hepatology 2001; 34: 834. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99. Barsoum J. Concentration of recombinant baculovirus by cation‐exchange chromatography. Biotechniques 1999; 26: 834–40. [DOI] [PubMed] [Google Scholar]
  • 100. Hu YC, Tsai CT, Chung YC, Lu JT, Hsu JT. Generation of chimeric baculovirus with histidine‐tags displayed on the envelope and its purification using immobilized metal affinity chromatography. Enzyme Microb Technol 2003; 33: 445–52. [Google Scholar]
  • 101. Sandig V, Hofmann C, Steinert S, Jennings G, Schlag P, Strauss M. Gene transfer into hepatocytes and human liver tissue by baculovirus vectors. Hum Gene Ther 1996; 7: 1937–45. [DOI] [PubMed] [Google Scholar]
  • 102. Gronowski AM, Hilbert DM, Sheehan KCF, Garotta G, Schreiber RD. Baculovirus stimulates antiviral effects in mammalian cells. J Virol 1999; 73: 9944–51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103. Beck NB, Sidhu JS, Omiecinski CJ. Baculovirus vectors repress phenobarbital‐mediated gene induction and stimulate cytokine expression in primary cultures of rat hepatocytes. Gene Ther 2000; 7: 1274–83. [DOI] [PubMed] [Google Scholar]
  • 104. Abe T, Takahashi H, Hamazaki H, Miyano‐Kurosaki N, Matsuura Y, Takaku H. Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice. J Immunol 2003; 171: 1133–9. [DOI] [PubMed] [Google Scholar]
  • 105. Aoki H, Sakoda Y, Jukuroki K, Takada A, Kida H, Fukusho A. Induction of antibodies in mice by a recombinant baculovirus expressing pseudorabies virus glycoprotein B in mammalian cells. Vet Microbiol 1999; 68: 197–207. [DOI] [PubMed] [Google Scholar]
  • 106. Facciabene A, Aurisicchio L, La Monica N. Baculovirus vectors elicit antigen‐specific immune responses in mice. J Virol 2004; 78: 8663–72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 107. Tami C, Farber M, Palma EL, Taboga O. Presentation of antigenic sites from foot‐and‐mouth disease virus on the surface of baculovirus and in the membrane of infected cells. Arch Virol 2000; 145: 1815–28. [DOI] [PubMed] [Google Scholar]
  • 108. Yoshida S, Kondoh D, Arai E, Matsuoka H, Seki C, Tanaka T, et al. Baculovirus virions displaying Plasmodium berghei circumsporozoite protein protect mice against malaria sporozoite infection. Virology 2003; 316: 161–70. [DOI] [PubMed] [Google Scholar]
  • 109. Baumert TF, Ito S, Wong DT, Liang TJ. Hepatitis C virus structural proteins assemble into viruslike particles in insect cells. J Virol 1998; 72: 3827–36. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110. O'Reilly D, Miller L, Luckow V. In: Baculovirus expression vectors: a laboratory manual. New York : WH Freeman and Co; 1992. [Google Scholar]

Articles from Acta Pharmacologica Sinica are provided here courtesy of Wiley

RESOURCES